Ignite Creation Date:
2025-12-25 @ 1:16 AM
Ignite Modification Date:
2026-02-21 @ 5:18 PM
Study NCT ID:
NCT07007793
Status:
RECRUITING
Last Update Posted:
2025-10-10
First Post:
2025-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2028-02-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02-18
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-16
First Submit QC Date:
None
Study First Post Date:
2025-06-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-09
Last Update Post Date:
2025-10-10
Last Update Post Date Type:
ESTIMATED